Riskpilot← Back to searchSign inGet full accessLundquist Medical ApS
APSActiveCVR 31261457Stubbevangen 27, st.Business and other management consultancy activities · NACE 7020Est. 20081 employees
Revenue 2025
DKK 741K
-6070% vs 2024
EBITDA margin
33.0%
+2069% vs 2024
Equity ratio
-185.6%
Financial strength
Net profit 2025
DKK -1,9M
-365% vs 2024
| Revenue | DKK 741K | -6070% |
| EBITDA | DKK 245K | +2069% |
| Net profit | DKK -1,9M | -365% |
| Total assets | DKK 2M | -43% |
| Equity | DKK -3,7M | -102% |
| Employees | 1 | — |
Legal name
Lundquist Medical ApS
CVR number
31261457
Legal form
Anpartsselskab
NACE code
7020 · Business and other management consultancy activities
Founded
31. januar 2008
Share capital
DKK 125.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-04-30
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør alene
Company purpose
Selskabets formål er at udføre konsulentbistand vedrørende virksomhedsrådgivning samt anden rådgivning og driftsledelse.
Address
Stubbevangen 27, st.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -3 | -3 | -3 | -5 | -4 | -5 | -8 | -13 | -11 | -11 | -11 | -12 | -12 | 741 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -497 |
| EBITDA | -3 | -3 | -3 | -5 | -4 | -5 | -8 | -13 | -11 | -11 | -11 | -12 | -12 | 245 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -3 | -3 | -3 | -5 | -4 | -5 | -8 | -13 | -11 | -11 | -11 | -12 | -12 | 245 |
| Net financials | 0 | 1 | 0 | -0 | -0 | -31 | -17 | -145 | -274 | -305 | -332 | -359 | -390 | -2.117 |
| Profit before tax | -3 | -3 | -3 | -5 | -4 | -36 | -25 | -159 | -285 | -316 | -343 | -371 | -403 | -1.873 |
| Tax | -1 | -1 | -0 | -1 | -1 | 5 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -2 | -2 | -3 | -4 | -3 | -41 | -25 | -159 | -285 | -316 | -343 | -371 | -403 | -1.873 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 122 | 120 | 117 | 117 | 111 | 75 | 2.282 | 3.117 | 3.481 | 3.484 | 3.482 | 3.480 | 3.480 | 1.998 |
| Equity | 119 | 117 | 115 | 110 | 107 | 66 | 41 | -118 | -404 | -720 | -1.062 | -1.433 | -1.836 | -3.709 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 2.224 | 3.203 | 3.841 | 4.144 | 4.474 | 4.830 | 5.214 | 5.553 |
| Short-term debt | 3 | 3 | 3 | 7 | 4 | 9 | 18 | 32 | 44 | 59 | 70 | 84 | 102 | 154 |
| Total debt | 3 | 3 | 3 | 7 | 4 | 9 | 2.242 | 3.235 | 3.884 | 4.203 | 4.544 | 4.914 | 5.316 | 5.707 |
EBITDA margin
33.0%
This company
15.8%
Market median
+109% vs market
20122025
Equity ratio
-185.6%
This company
38.2%
Market median
-586% vs market
20122025
Return on equity
-187258000.0%
This company
18.4%
Market median
-1017706622% vs market
20122025
Net profit margin
-252.6%
This company
8.1%
Market median
-3219% vs market
20122025
Asset turnover
0.37×
This company
1.12×
Market median
-67% vs market
20122025
Debt / equity
1.54×
This company
0.62×
Market median
-148% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via CVR / Virk · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via CVR / Virk · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via CVR / Virk · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via CVR / Virk · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via CVR / Virk · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via CVR / Virk · Period 2018-05-01 – 2019-04-30
- Annual report 2018Filed via CVR / Virk · Period 2017-05-01 – 2018-04-30
- Annual report 2017Filed via CVR / Virk · Period 2016-05-01 – 2017-04-30
- Annual report 2016Filed via CVR / Virk · Period 2015-05-01 – 2016-04-30
- Annual report 2015Filed via CVR / Virk · Period 2014-05-01 – 2015-04-30
- Annual report 2014Filed via CVR / Virk · Period 2013-05-01 – 2014-04-30
- Annual report 2013Filed via CVR / Virk · Period 2012-05-01 – 2013-04-30
- Annual report 2012Filed via CVR / Virk · Period 2011-05-01 – 2012-04-30
No data on file.
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2008 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Lundquist Medical ApS 
RAM BIOTECH ApSBoard members of Lundquist Medical ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|